Viveve Medical (VIVE) Competitors $0.0002 0.00 (0.00%) As of 01:02 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VIVE vs. NMRD, UTRS, MOTS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, and BRSHShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Bruush Oral Care (BRSH). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Nemaura Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Nemaura Medical (NASDAQ:NMRD) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk. Do institutionals & insiders have more ownership in NMRD or VIVE? 4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by company insiders. Comparatively, 5.7% of Viveve Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, NMRD or VIVE? Nemaura Medical has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Does the media favor NMRD or VIVE? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Viveve Medical Neutral Which has preferable earnings and valuation, NMRD or VIVE? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K0.00-$14.14M-$0.39N/AViveve Medical$6.83M0.00N/AN/AN/A Is NMRD or VIVE more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Viveve Medical N/A N/A N/A Does the MarketBeat Community prefer NMRD or VIVE? Viveve Medical received 307 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Viveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% SummaryNemaura Medical and Viveve Medical tied by winning 3 of the 6 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2,000.00$3.19B$5.49B$7.95BDividend YieldN/A1.80%5.11%4.22%P/E RatioN/A15.6022.6218.58Price / Sales0.0055.62397.85103.49Price / CashN/A44.0938.1834.62Price / BookN/A3.546.744.25Net IncomeN/A$94.03M$3.22B$248.18M7 Day PerformanceN/A4.10%1.59%1.36%1 Month PerformanceN/A7.53%4.09%3.85%1 Year PerformanceN/A-17.47%15.98%5.37% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070NMRDNemaura MedicalN/A$0.00flatN/A-99.8%$8,000.00$3,017.000.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/A$0.00flatN/AN/A$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.22+6.8%N/A-17.2%$0.00N/A0.0080Gap UpANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.02-2.6%N/A-62.3%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$20.20-2.9%N/A-29.3%$0.00N/A0.002Gap DownBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011Positive NewsBRSHBruush Oral CareN/A$0.00flatN/A-98.6%$0.00$2.92M0.0011 Related Companies and Tools Related Companies Nemaura Medical Competitors Minerva Surgical Competitors Motus GI Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Assure Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Bruush Oral Care Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.